Page 6 - Lancet Glob News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Optimizing the Preventive Power of HPV Vaccine Introduction among AGYW in India

Ideas for introducing the HPV vaccine in India

Uttar pradeshUnited statesWest bengalKruppk srinivasPreetika banerjeeIpsita bhattacharjeeLit srinivasRegional medical advisor for women healthGlobal cervical cancer elimination initiativeHealth promotion practiceBanke thomasa associationCommunity perspectives from uttar pradeshIndia incFred hutchinson cancer centerPublic health sciences divisionReprod health

Innovent Announces First Participant Dosed in Phase 1 Clinical Study of IBI333 (VEGF-A/VEGF-C Bispecific Fusion Protein) in Patients with Neovascular Age-related Macular Degeneration

/PRNewswire/ Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.

Hong kongInnovent biologicsYouxin chenAdimab incyteEli lillyClinical development of innoventMd anderson cancer centerUnion medical college hospitalLancet glob healthInnovent biologics incPeking union medical college hospitalPrincipal investigatorLei qianVice presidentClinical developmentMain board

Essex Bio-Technology Limited: First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases

HONG KONG, Feb 10, 2023 - (ACN Newswire) - Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced that the first patient in the United States (US) was dosed in a global

United statesAngela shenYan liOuyang lingyiEssex bioZhonghua shiyan yanke zazhiJune tuoXing yiqiaoShelly chengTechnology ltd essexStudy groupWorld health organizationResearch groupShanghai henlius biotech incStrategic financial relations limited websiteEuropean union

acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesAngela shenYan liOuyang lingyiEssex bioZhonghua shiyan yanke zazhiJune tuoXing yiqiaoShelly chengTechnology ltd essexStudy groupWorld health organizationResearch groupShanghai henlius biotech incStrategic financial relations limited websiteEuropean union

Pfizer Announces Positive Top-Line Data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate

Pfizer Announces Positive Top-Line Data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate
pfizer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pfizer.com Daily Mail and Mail on Sunday newspapers.

United statesAnnaliesa andersonEricaf simCenters for diseaseVaccine research developmentNational institutes of healthDrug administrationData monitoring committeeExchange commissionPfizer incUniversity of colorado school medicineLancet glob healthImmunization studySenior vice presidentChief scientific officerVaccine research